IFNG and cancer: To show that PD-1 expression identifies cancer antigen-reactivity in another hematologic malignancy model (C1498 acute myeloid leukemia), the percentages and absolute numbers of cancer-reactive cells were determined, and IFN-γ ELISPOT assays performed on T cells harvested from mice bearing C1498.